Disappearance of Both the BCR/ABL1 Fusion Gene and the JAK2V617F Mutation with Dasatinib Therapy in a Patient with Imatinib-Resistant Chronic Myelogenous Leukemia

Koiti Inokuchi; Hiroki Yamaguchi; Hayato Tamai; Kazuo Dan

doi:10.3960/jslrt.52.145

Journal of Clinical and Experimental Hematopathology

Online ISSN : 1880-9952
Print ISSN : 1346-4280
ISSN-L : 1346-4280

Letter to the Editor

Disappearance of Both the BCR/ABL1 Fusion Gene and the JAK2V617F Mutation with Dasatinib Therapy in a Patient with Imatinib-Resistant Chronic Myelogenous Leukemia

Koiti Inokuchi, Hiroki Yamaguchi, Hayato Tamai, Kazuo Dan

Author information

Keywords: JAK2V617F, CML, dasatinib

JOURNAL FREE ACCESS

2012 Volume 52 Issue 2 Pages 145-147

DOI https://doi.org/10.3960/jslrt.52.145

Details

Article 1st page

Content from these authors

Favorites & Alerts

Corresponding author

Register with J-STAGE for free!